Solabia Group today announced the completion of its acquisition of Mibelle Biochemistry, the Swiss specialist in science-backed active ingredients for the cosmetics and nutraceutical industries, from Persán, under the terms announced on 19 February 2026.

A new study conducted by ETH Zurich and the University Hospital Zurich, with support from Mibelle Biochemistry and the Mibelle Group, reveals fresh insights into how UVA light accelerates mitochondrial aging in the skin.